Have any questions?
+44 1234 567 890
TOPICS
With the motto „Immunotherapies – Advances and Adaptions“ the German Sepsis Society takes up the situation of the critical care community that has been confronted with the Corona pandemic. SARS-CoV-2 as a new pathogen has expanded the diverse range of sepsis pathogens. The meeting will give outstanding researchers the opportunity to report on the latest advances in immunomodulatory approaches to the adaptive immune response in sepsis.
Get up to date on the current state of knowledge about the latest diagnostic and therapeutic advances of sepsis. Meet your colleagues and friends in your field and exchange ideas and experiences with them.
Immunotherapies – Advances and Adaptions
- Subendotypes to detect treatment responders
- Biomarkers for predictive enrichment
- Adaptive trial design and platform trials
- GWAS for detection of relevant mechanisms
- Omics technologies
- Mesenchymal stem cell therapy
- Immune checkpoint inhibitors
- Plasma exchange and sorbents
- Monoclonal antibodies – new kids on the block
- Nebulized therapies
- Corticosteroids revisited
- Vitamins and micronutrients
- Host response and causative pathogen
- Gut microbiome in sepsis
- Secondary viral reactivation
- HPA-axis in sepsis
- Sepsis numbers: what counts?
- Equipoise for ECMO
- Bundles of care for sepsis
- Controversies in hemodynamic management
- Balanced crystalloids or saline?
- AI for clinical decision support?
- Long-term outcomes of sepsis
Get the latest updates!
Newsletter
Subscribe to our newsletter to receive the latest news and updates about Sepsis Update!
You can unsubscribe from the mailing list at any time.
By clicking on 'Subscribe' you agree to receive the newsletter with information on Sepsis Update, as well as to its analysis through individual measurement, storage, and evaluation of opening rates and the click rates in recipient profiles for the purpose of designing future newsletters according to the interests of our readers. You can unsubscribe at any time. Please find detailed information in our privacy policy.